Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Teva Pharmaceutical Industries Ltd.
FDA Inspection
•Teva Pharmaceutical Industries Ltd.•May 23, 2023

Teva Pharmaceutical Industries Ltd. – FDA Inspection, May 23, 2023

Record Details

This FDA Inspection record concerns Teva Pharmaceutical Industries Ltd., with an inspection on May 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Teva Pharmaceutical Industries Ltd.
Inspection Date
May 23, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Michael Araneta (Company Rep)
  • Sean R. Marcsisin (FDA Associated Person)
View Company Profile

ID · 0571d0c0-bd92-486e-add6-268f4e519233

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1207104
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

10
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.113(b)Procedures for sterile drug products
  4. 21 CFR 211.67(b)(6)Cleaning SOP/inspection
  5. 21 CFR 211.192Investigations of discrepancies, failures
  6. 21 CFR 211.113(b)Procedures for sterile drug products
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  9. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  10. 21 CFR 211.67(b)(6)Cleaning SOP/inspection

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Teva Pharmaceutical Industries Ltd.

7
DateClassificationOfficeProject area
September 22, 2019Not classifiedOffice of Inspections and Investigations
July 25, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 25, 2017Not classifiedOffice of Inspections and Investigations
June 15, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 18, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Teva Pharmaceutical Industries Ltd.
  • FDA Inspection 1111726 - 2019-09-22
  • FDA Inspection 1099394 - 2019-07-25
  • FDA Inspection 1016187 - 2017-05-25
  • FDA Inspection 935223 - 2015-06-15
  • FDA Inspection 849301 - 2013-07-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teva Pharmaceutical Industries Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.